Investing

Québec Communities Vote “No” to La Loutre Graphite Mine

September 6, 2025
Investing

Top 5 Canadian Mining Stocks This Week: Carlton Precious Gains 78 Percent

September 6, 2025
Investing

Lode Gold Closes $1.51 Million Upsized Private Placement

September 6, 2025
Investing

Editor’s Picks: Gold Sets New Price Record, Silver Hits 14 Year High

September 6, 2025
Politics

EXCLUSIVE: Franklin Graham praises VP Vance’s stand, critiques his ‘salty’ language in RFK Jr. defense

September 6, 2025
Politics

Loyal Ex-Biden aide says fateful debate against Trump was ‘overblown’ in closed-door House grilling

September 6, 2025
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Tudor to Acquire American Creek in Latest Gold...

June 27, 2025

Shanghai Platinum Week Showcases China’s Dominance in Global...

July 21, 2025

Walker Lane Resources: Advancing High-grade Gold, Silver assets...

April 24, 2025

Tech 5: NVIDIA Hits Market Cap Milestone, Harmonic...

July 14, 2025

Crypto Market Recap: Bitcoin Breaks US$111,000, Trump Courts...

May 24, 2025

Earthwise Advertising & Investor Awareness Campaign

August 30, 2025

John Ciampaglia: Uranium Turnaround? Spot Price Pop, Stocks...

June 27, 2025

Questcorp Mining Completes 25 Percent of Maiden Drilling...

August 19, 2025

Top 5 Junior Copper Stocks on the TSXV...

April 17, 2025

Skyharbour Resources

August 1, 2025